Evidence map›Paper›PMID 30824372›Full record

ArticleMolecular cell2019

P-TEFb Activation by RBM7 Shapes a Pro-survival Transcriptional Response to Genotoxic Stress.

Andrii Bugai, Alexandre J C Quaresma, Caroline C Friedel, Tina Lenasi, Robert Düster, Christopher R Sibley, Koh Fujinaga, Petra Kukanja, Thomas Hennig, Melanie Blasius and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. AScience signaling · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 5 countries.

Andrii BugaiDepartment of Biochemistry and Developmental Biology, University of Helsinki, Helsinki 00014, Finland.
Alexandre J C QuaresmaDepartment of Biochemistry and Developmental Biology, University of Helsinki, Helsinki 00014, Finland.
Caroline C FriedelInstitute for Informatics, Ludwig-Maximilians-Universität München, 80333 Munich, Germany.
Tina LenasiDepartment of Biochemistry and Developmental Biology, University of Helsinki, Helsinki 00014, Finland.
Robert DüsterInstitute of Structural Biology, University of Bonn, 53127 Bonn, Germany.
Christopher R SibleyDivision of Brain Sciences, Department of Medicine, Imperial College London, London W12 0NN, UK; MRC-Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Koh FujinagaDepartments of Medicine, Microbiology, and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.
Petra KukanjaDepartment of Biochemistry and Developmental Biology, University of Helsinki, Helsinki 00014, Finland.
Thomas HennigInstitute for Virology and Immunobiology, University of Würzburg, 97078 Würzburg, Germany.
Melanie BlasiusDepartment of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, 2200 Copenhagen, Denmark.
Matthias GeyerInstitute of Structural Biology, University of Bonn, 53127 Bonn, Germany.
Jernej UleMRC-Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK; Institute of Neurology, University College London, London WC1N 3BG, UK; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Lars DölkenInstitute for Virology and Immunobiology, University of Würzburg, 97078 Würzburg, Germany.
Matjaž BarboričDepartment of Biochemistry and Developmental Biology, University of Helsinki, Helsinki 00014, Finland. Electronic address: matjaz.barboric@helsinki.fi.
University of Helsinki · FIUniversity of Bonn · DEUniversity of Würzburg · DELudwig-Maximilians-Universität München · DEMRC Laboratory of Molecular Biology · GBThe Francis Crick Institute · GBUniversity of California, San Francisco · USUniversity of Copenhagen · DK

Funding

Medical Research Council MC_U105185858Wellcome Trust FC001002
6 · The paper itself

Abstract

DNA damage response (DDR) involves dramatic transcriptional alterations, the mechanisms of which remain ill defined. Here, we show that following genotoxic stress, the RNA-binding motif protein 7 (RBM7) stimulates RNA polymerase II (Pol II) transcription and promotes cell viability by activating the positive transcription elongation factor b (P-TEFb) via its release from the inhibitory 7SK small nuclear ribonucleoprotein (7SK snRNP). This is mediated by activation of p38

Indexed as

Transcription, GeneticApoptosisCell SurvivalDNA DamageHEK293 CellsHumansp38 Mitogen-Activated Protein KinasesPositive Transcriptional Elongation Factor BRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA, Long NoncodingRNA Polymerase IIlong non-coding RNA 7SK, humanp38 Mitogen-Activated Protein KinasesPositive Transcriptional Elongation Factor BRBM7 protein, humanRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA, Long NoncodingRNA Polymerase II7SK snRNPapoptosisCDK9DNA damage responsegenotoxic stressp38 MAP kinasePol II elongationPol II pause releaseP-TEFbRBM7

Identifiers

PMID30824372
PMCPMC6482433
OpenAlexW2886134017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.